Novalis Biotechnology Incubation logo

Novalis Biotechnology Incubation

Europe, Oost-Vlaanderen, Belgium, Gent

Description

Novalis Biotech Incubation is an early-stage vc fund that invests in biotechnology and life sciences related companies.

Investor Profile

Novalis Biotechnology Incubation has backed more than 12 startups, with 1 new investments in the last 12 months alone. The firm has led 7 rounds, about 58% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Debt Financing rounds (top funding stages).
  • Majority of deals are located in United States, The Netherlands, France.
  • Strong thematic focus on Health Care, Biotechnology, Medical Device.

Stage Focus

  • Seed (58%)
  • Series A (33%)
  • Debt Financing (8%)

Country Focus

  • United States (25%)
  • The Netherlands (17%)
  • France (17%)
  • Belgium (17%)
  • Switzerland (8%)
  • Germany (8%)
  • Sweden (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Natural Language Processing
  • Software
  • Video
  • Biopharma
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Novalis Biotechnology Incubation frequently co-invest with?

PV
North America, California, United States, San Francisco
Co-Investments: 1
Risk and Return
North America, Virginia, United States, Mclean
Co-Investments: 2
Lair East Labs
North America, New York, United States, New York
Co-Investments: 1
SH
North America, Texas, United States, Dallas
Co-Investments: 3
CH
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Threshold Impact
North America, Alberta, Canada, Edmonton
Co-Investments: 2
Relentless Pursuit Partners
North America, British Columbia, Canada, Vancouver
Co-Investments: 3
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 2
Alchemist Accelerator
North America, California, United States, San Francisco
Co-Investments: 1
Voxel Ventures
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1

Which angels does Novalis Biotechnology Incubation often collaborate with?

Ray Muzyka
North America, Alberta, Canada, Edmonton
Shared Deals: 1

What are some of recent deals done by Novalis Biotechnology Incubation?

Altavo

Dresden, Sachsen, Germany

Altavo operates as a medical device startup.

Health CareManufacturingMedical Device
Series AJan 22, 2026
Amount Raised: $3,515,301
Modality.AI, Inc.

San Francisco, California, United States

Self-Driven Neurological Assessments

Artificial Intelligence (AI)Health CareMachine LearningNatural Language ProcessingSoftwareVideo
SeedOct 7, 2024
Amount Raised: $570,523
Alithea Genomics

Lausanne, Vaud, Switzerland

Alithea Genomics backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.

BiopharmaBiotechnology
SeedMar 14, 2024
Amount Raised: $3,166,285
Altavo

Dresden, Sachsen, Germany

Altavo operates as a medical device startup.

Health CareManufacturingMedical Device
Series AFeb 20, 2024
Amount Raised: $5,404,950
Rarity Bioscience

Uppsala, Uppsala Lan, Sweden

Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.

BiotechnologyHealth CareMedical
SeedFeb 6, 2023
Amount Raised: $536,453
Enzyre

Nijmegen, Gelderland, The Netherlands

Enzyre is a developer of diagnostic technology.

Health CareMedical Device
Series ANov 2, 2022
Amount Raised: $11,776,679
Modality.AI, Inc.

San Francisco, California, United States

Self-Driven Neurological Assessments

Artificial Intelligence (AI)Health CareMachine LearningNatural Language ProcessingSoftwareVideo
SeedOct 7, 2022
Amount Raised: $1,119,113
Carroucell

Sainte-hélène-du-lac, Rhone-Alpes, France

Carroucell is the microcarrier supplier for cell culture in bioreactor.

BiotechnologyTherapeutics
Series ASep 7, 2022
Amount Raised: $1,499,697
Trince

Asse, Vlaams-Brabant, Belgium

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

BiopharmaBiotechnologyGenetics
SeedDec 4, 2021
Amount Raised: $4,525,598
Modality.AI, Inc.

San Francisco, California, United States

Self-Driven Neurological Assessments

Artificial Intelligence (AI)Health CareMachine LearningNatural Language ProcessingSoftwareVideo
SeedJul 30, 2021
Amount Raised: $2,520,765

Find More Investors Like Novalis Biotechnology Incubation

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Novalis Biotechnology Incubation | Pipeseed